Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-β receptor inhibitor on extravasation of nanoparticles from neovasculature-Reference-Cited by-同舟云学术

Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-β receptor inhibitor on extravasation of nanoparticles from neovasculature

Published:2009-01 Issue:1 Volume:100 Page:173-180
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Kano Mitsunobu R.,Komuta Yukari,Iwata Caname,Oka Masako,Shirai Yo-taro,Morishita Yasuyuki,Ouchi Yasuyoshi,Kataoka Kazunori,Miyazono Kohei

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2008.01003.x/fullpdf

Reference25 articles.

1. p8 is a new target of gemcitabine in pancreatic cancer cells;Giroux;Clin Cancer Res,2006

2. Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft models;Merriman;Invest New Drugs,1996

3. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer;Rothenberg;Ann Oncol,1996

4. The hallmarks of cancer;Hanahan;Cell,2000

5. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors;Jain;Cancer Res,1990

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PF-06952229, a selective TGF-β-R1 inhibitor: preclinical development and a first-in-human, phase I, dose-escalation study in advanced solid tumors;ESMO Open;2024-09

2. Efficacy and safety of hepatic arterial infusion chemotherapy combined with fruquintinib and tislelizumab for patients with microsatellite stable colorectal cancer liver metastasis following failure of multiple-line therapy;Frontiers in Oncology;2024-08-20

3. Monitoring imatinib decreasing pericyte coverage and HIF-1α level in a colorectal cancer model by an ultrahigh-field multiparametric MRI approach;Journal of Translational Medicine;2024-07-31

4. Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib;Molecular and Clinical Oncology;2024-07-10

5. Management Consensus Guidelines for Hepatocellular Carcinoma: 2023 Update on Surveillance, Diagnosis, Systemic Treatment, and Posttreatment Monitoring by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan;Liver Cancer;2024-02-12